Evidence map›Paper›PMID 31104076›Full record

ArticleEuropean journal of clinical pharmacology2019

Towards a "prescribing license" for medical students: development and quality evaluation of an assessment for safe prescribing.

David R M Jansen, Carolina J P W Keijsers, Michiel O Kornelissen, Marcel G M Olde Rikkert, Cornelis Kramers, (on behalf of the education working group of the Dutch Society for Clinical Pharmacology and Biopharmacy)

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Reimagining pharmacology education.Pharmacological reviews · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. WHO guide to good prescribing is 25 years old: quo vadis?European journal of clinical pharmacology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

David R M JansenDepartment of Geriatric Medicine, Radboud University Medical Center, P.O. box 9101, 6500 HB, Nijmegen, The Netherlands. david.jansen@radboudumc.nl.ORCID http://orcid.org/0000-0002-4478-4340
Carolina J P W KeijsersDepartment of Geriatric Medicine, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
Michiel O KornelissenRadboudumc Health Academy, Radboud University Medical Center, Nijmegen, The Netherlands.
Marcel G M Olde RikkertDepartment of Geriatric Medicine, Radboud University Medical Center, P.O. box 9101, 6500 HB, Nijmegen, The Netherlands.
Cornelis KramersDepartment of Pharmacology and Toxicology and Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
(on behalf of the education working group of the Dutch Society for Clinical Pharmacology and Biopharmacy)
Radboud University Nijmegen · NLJeroen Bosch Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis report describes the development and validation process of an assessment with national consensus in appropriate and safe pharmacotherapy.

methodsA question-database on safe prescription based on literature of pharmacotherapy-related harm was developed by an expert group from Dutch medical faculties. Final-year medical students concluded a 2-year education program on appropriate and safe prescription by one of nine assessment variants of 40 multiple-choice questions each. An expert panel of professionals (n = 10) answered all database questions and rated questions on relevance. Questions were selected for revision based on lack of relevance or poor test and item characteristics.

resultsA total of 576 final-year medical students of the Radboud University was assessed. There was no significant difference in performance between students and content expert group (p = 0.7), probably due to learning behavior. Out of 165 questions, 59 were selected for revision.

conclusionJoint national effort from a team of experts in prescription and pharmacotherapy is an appropriate way to achieve a valid and reliable last-year student drug prescription assessment.

Indexed as

Education, Medical, UndergraduateEducation, PharmacyStudents, MedicalSurveys and QuestionnairesDrug PrescriptionsDrug-Related Side Effects and Adverse ReactionsFemaleHumansLicensureMaleNetherlandsReproducibility of ResultsEducationMedication safetyPrescribing

Identifiers

PMID31104076
OpenAlexW2946346596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.